Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series.
Journal: Lancet (London, England)
Published: November 19, 2024
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis.
Journal: Clinical kidney journal
Published: April 06, 2021
Author Correction: A novel assay to measure calcification propensity: from laboratory to humans.
Journal: Scientific reports
Published: February 17, 2021
A novel assay to measure calcification propensity: from laboratory to humans.
Journal: Scientific reports
Published: November 12, 2019
Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis.
Journal: Journal of nephrology
Published: March 30, 2019
Addition of exenatide BID to insulin glargine: a post-hoc analysis of the effect on glycemia and weight across a range of insulin titration.
Journal: Current medical research and opinion
Published: March 14, 2014
Showing 1-6 of 6
Last Updated: 09/26/2026